Yahoo
NYSE - Delayed Quote USD

Pediatrix Medical Group, Inc. (MD)

27.03 +0.15 (+0.56%)
At close: September 4 at 4:00:02 PM EDT
27.03 0.00 (0.00%)
After hours: 8:00:00 PM EDT
Trade MD on Coinbase
Chart Range Bar
Loading chart for MD
  • Previous Close 26.88
  • Open 26.65
  • Bid 26.99 x 60000
  • Ask 27.05 x 30000
  • Day's Range 26.71 - 27.07
  • 52 Week Range 15.70 - 27.94
  • Volume 532,944
  • Avg. Volume 799,638
  • Market Cap (intraday) 2.196B
  • Beta (5Y Monthly) 0.65
  • PE Ratio (TTM) 12.87
  • EPS (TTM) 2.10
  • Earnings Date Nov 2, 2026
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 26.33

Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, and other pediatric subspecialty care services in the United States. The company offers clinical care to babies born prematurely or with complications within specific units at hospitals, primarily NICUs, through its network of affiliated neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians; and inpatient and office-based clinical care to expectant mothers and unborn babies through its affiliated maternal-fetal medicine subspecialists, obstetricians and other clinicians, maternal-fetal medicine nurse practitioners, certified nurse midwives, sonographers, and genetic counselors. It also provides other pediatric subspecialty care, including pediatric intensivists, pediatric hospitalists, and pediatric surgeons; support services in other areas of hospitals comprising pediatric emergency room, labor and delivery area, and nursery and pediatric departments; a newborn hearing screening program. The company was formerly known as MEDNAX, Inc. and changed its name to Pediatrix Medical Group, Inc. in July 2022. Pediatrix Medical Group, Inc. was founded in 1979 and is based in Sunrise, Florida.

www.pediatrix.com

4,280

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 9/4/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

MD
26.37%
S&P 500 (^GSPC)
12.75%

1-Year Return

MD
58.91%
S&P 500 (^GSPC)
18.71%

3-Year Return

MD
93.49%
S&P 500 (^GSPC)
70.93%

5-Year Return

MD
12.72%
S&P 500 (^GSPC)
70.18%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY26
Revenue 487.78M
Earnings 39.84M
Profit Margin 8.17%

Q3

FY25

Q4

FY25

Q1

FY26

Q2

FY26

0
100M
200M
300M
400M
8.0%
10.0%
12.0%
14.0%

Analyst Insights

View More

Analyst Price Targets

21.00 Low
26.33 Average
27.03 Current
28.00

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 8/19/2026
Analyst Jefferies
Rating Action Downgrade
Rating Hold
Price Action Raises
Price Target 27 -> 28

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (5yr expected)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    8.96%

  • Return on Assets (ttm)

    7.11%

  • Return on Equity (ttm)

    20.39%

  • Revenue (ttm)

    1.95B

  • Net Income Avi to Common (ttm)

    174.81M

  • Diluted EPS (ttm)

    2.10

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    404.2M

  • Total Debt/Equity (mrq)

    70.37%

  • Levered Free Cash Flow (ttm)

    160.78M

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: